drugset / Trial / NCT01537497

A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers

NCT01537497

Phase 1 Completed 31 enrolled Pfizer
RandomizedParallel-groupDouble-blindBasic science

Summary

The primary purpose of this study is to evaluate pharmacodynamics of single oral doses of PF-05175157 in a dose-dependent fashion in healthy volunteers

Timeline

Start
2012-03
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-05175157 Small molecule 100 mg Oral
Subject PF-05175157 Small molecule 250 mg Oral
Subject PF-05175157 Small molecule 600 mg Oral